About Wegovy®
Wegovy® is a prescription medicine that can help you lose weight and support your heart health.
The benefits of managing your weight aren’t measured in the kilos you’ve lost, but in the personal things you overcome or regain due to your weight-loss.
Wegovy® is a prescription medicine that can help you lose weight and support your heart health.
Explore whether you may be suitable for Wegovy® with our quick quiz and BMI calculator.
If you're ready to live a life beyond the kilos, start by speaking with a healthcare provider.
Obesity is a complex medical condition and losing weight isn't just about willpower, eating less or moving more. Your genes, hormones and environment can all make it harder to lose weight and keep it off.
Wegovy® is a once-weekly injectable prescription medicine that contains semaglutide. It can help you lose weight and support your heart health when used alongside healthy changes to your diet and physical activity.
Wegovy®* doesn’t just help you lose weight, it helps you keep if off while you stay on treatment:
If you have heart disease and are overweight§ (but don’t have diabetes) Wegovy®^ may also help reduce the risk of serious heart events like heart attack, stroke or death.
Wegovy® works by mimicking a natural hormone called GLP-1, also known as glucagon-like peptide-1, which helps your brain better regulate appetite. By increasing GLP-1 activity, Wegovy® leads to reduced hunger, improved control over cravings, and feeling satisfied with less food.
Whether you're exploring treatment options or just looking to learn more, our simple quiz and BMI calculator can help. In just a few steps, you’ll find out if you may be suitable for a Wegovy® prescription.
To help get you started, we've put together a quick quiz to explore where you are in your weight-management journey. Use your results to start the conversation with a healthcare provider about your weight to see if Wegovy® might be right for you.
Body Mass Index (BMI) is a simple tool that uses your height and weight to estimate whether you're in a healthy weight range. While it doesn’t measure body fat directly, it’s a useful starting point for understanding your weight category.
Remember, BMI is not a diagnostic tool. It’s important to talk to a healthcare provider about your results, as they may also consider other measures, like your waist size, to better understand your overall health and risk factors.
Wegovy® is used for weight loss and weight maintenance, alongside healthy changes to diet and physical activity in adults, who have an initial:
Wegovy® is also used to reduce the risk of heart disease-related events in adults who have a history of heart disease, do not have diabetes, and have a BMI of 27 kg/m2 or more.
Treatment begins with a low dose that’s gradually increased. This step-by-step approach is designed to reduce the chance of side effects like nausea, constipation, diarrhoea, or vomiting.
If these occur, they are usually mild and short-lived but always speak to a healthcare provider if you experience any side effects.
To find out more about Wegovy® and potential side effects, please view the Consumer Medicine Information.
Wegovy® is a prescription medicine. If you're ready to take the next step in your weight-management journey, start by speaking with a healthcare provider. They can help you decide if Wegovy® is right for you, based on your personal health goals and needs.
Find a GP
Moshy is an independent online health clinic offering personalised obesity care including unlimited online consultations, medication shipped to your door, a 12-week onboarding programme and all in one support app with recipes, nutritional guidance, health tracking and access to support tools for sustainable weight-loss results.
Visit Moshy
wegovycare® is an app-based programme that offers tips, guidance, and practical tools to support you as you start and stay on track with your Wegovy® treatment. The wegovycare® app is only available to people prescribed Wegovy® by their healthcare provider in accordance with the approved indication in New Zealand.
If you're starting Wegovy® treatment
When you’re thinking about starting a new medicine, it’s natural to have questions. Your healthcare provider is always the best person to talk to, but you might find the information below helpful too.
BMI: body mass index; GLP-1: glucagon-like peptide-1.
Wegovy® is an unfunded prescription medicine - payment for this medicine and any additional doctor and pharmacy fees will be required.
Wegovy® is used for weight loss and weight maintenance in addition to diet and physical activity in adults and adolescents ages 12 years and above who meet certain Body Mass Index (BMI) criteria. Wegovy® is also indicated to reduce the risk of a heart disease related event in addition to standard of care if you are an adult with a history of heart disease and have a BMI ≥27 kg/m2 without established diabetes. Wegovy® contains the active ingredient semaglutide and is available in the following dose forms: 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg and 2.4 mg. The two lower dose pens contain 1.5 mL of liquid each, while the three higher dose pens contain 3 mL each. Wegovy® has risks and benefits. Ask your doctor if Wegovy® is right for you. Use strictly as directed. If you experience side effects, see your doctor, pharmacist, or healthcare professional. Side effects of Wegovy® include nausea, vomiting, diarrhoea, constipation, abdominal pain, headache, fatigue. Please refer to the Wegovy® Consumer Medicine Information available at www.medsafe.govt.nz, in your Wegovy® pack or via https://www.novonordisk.co.nz/our-products/our-products.html before taking your medicine.
The link you clicked will take you to a site maintained by a third-party. Novo Nordisk does not control this site and is not responsible for the content, which may not follow local regulatory requirements. The link is provided for informational purposes only and not as advice.
The healthcare professionals available at this third-party site are independent to Novo Nordisk and will exercise their own clinical judgement in assessing your medical condition. You are encouraged to undertake your own independent research prior to selecting a healthcare provider.
Do you wish to continue?